nach oben

Erschienen in:

01.12.2014

Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway

verfasst von: Gali Epstein Shochet, Shelly Tartakover-Matalon, Liat Drucker, Metsada Pasmanik-Chor, Meir Pomeranz, Ami Fishman, Michael Lishner

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Women diagnosed with pregnancy associated breast cancer often have advanced cancer with metastases and reduced expression of ERα compared to non-pregnant women. Nevertheless, metastases to the placenta are uncommon. Previously, we demonstrated that breast cancer cells (MCF-7/T47D) migrated from ex vivo human placental explant implantation sites. We aimed to analyze the effect of factors produced during placental implantation or as a result of the interaction between the implanted placentae to cancer cells on cancer cells migration and aggressiveness. We collected supernatants from implanted placentae and placental-breast cancer cells cocultures and analyzed their effects on cancer cells phenotype and pathways. Supernatants collected from breast cancer cells served as controls. We found that supernatants collected from implanted placentae induced modest cancer cells migration that was not accompanied by epithelial to mesenchymal transition (EMT), supported breast cancer cells survival and elevated MCF-7 cell number. The coculture supernatant induced excessive motility and EMT of the MCF-7 cells. This EMT was mediated by Smad3 and JNK/ERK activation. Both placenta and coculture supernatants reduced ERα expression in the cancer cells. Finally, we showed that MCF-7 cocultured with the human placental explants underwent continuous activation of JNK and Smad3 pathways and the EMT process, which led to their migration away from the placental implantation sites. These findings may explain the reduced ERα and elevated metastases found in breast cancer during pregnancy and highlights pathways involved in it.

Stensheim H, Moller B, Van Dijk T, Fossa SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27(1):45–51PubMedCrossRef

Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, Halaska M, Vergote I, Ottevanger N, Amant F (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28(4):683–689PubMedCrossRef

Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7(4):279–287PubMed

Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe SB, Koren G (1992) Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 166(3):781–787PubMedCrossRef

Gasim T, Al Dakhiel SA, Al Ghamdi AA, Al Ali M, Al Jama F, Rahman J, Al Suleiman SA, Rahman MS (2010) Ovarian tumors associated with pregnancy: a 20-year experience in a teaching hospital. Arch Gynecol Obstet 282(5):529–533PubMedCrossRef

Ulery M, Carter L, Mcfarlin BL, Giurgescu C (2009) Pregnancy-associated breast cancer: significance of early detection. J Midwife Womens Health 54(5):357–363CrossRef

Amant F, Von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, Muller V, Van Calsteren K, Rack B, Nekljudova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, Van Calster B, Loibl S (2013) Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 31(20):2532–2539PubMedCrossRef

Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A (2010) Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 16(1):76–82PubMedCrossRef

Genin AS, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R (2012) Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? Breast 21(4):550–555PubMedCrossRef

10.

Baulies S, Cusido M, Tresserra F, Rodriguez I, Ubeda B, Ara C, Fabregas R (2014) Pregnancy-Associated Breast Cancer: an analytical observational study. Med Clin (Barc) 142(5):200–204CrossRef

11.

Madaras L, Kovacs KA, Szasz AM, Kenessey I, Tokes AM, Szekely B, Baranyak Z, Kiss O, Dank M, Kulka J (2013) Clinicopathological features and prognosis of pregnancy associated breast cancer—a matched case control study. Pathol Oncol Res 20:581–590PubMedCrossRef

12.

Johansson AL, Andersson TM, Hsieh CC, Cnattingius S, Lambe M (2011) Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 20(9):1865–1872PubMedCrossRef

13.

Ali SA, Gupta S, Sehgal R, Vogel V (2012) Survival outcomes in pregnancy associated breast cancer: a retrospective case control study. Breast J 18(2):139–144PubMedCrossRef

14.

Dimitrakakis C, Zagouri F, Tsigginou A, Marinopoulos S, Sergentanis TN, Keramopoulos A, Zografos GC, Ampela K, Mpaltas D, Papadimitriou C, Dimopoulos MA, Antsaklis A (2013) Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study. Breast Care (Basel) 8(3):203–207CrossRef

15.

Shousha S (2000) Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch Pathol Lab Med 124(7):1053–1060PubMed

16.

Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J, Scholtens D, Khan SA (2012) Association between recency of last pregnancy and biologic subtype of breast cancer. Ann Surg Oncol 19(4):1167–1173PubMedCrossRef

17.

Platet N, Cathiard AM, Gleizes M, Garcia M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51(1):55–67PubMedCrossRef

18.

Zeng Q, Li W, Lu D, Wu Z, Duan H, Luo Y, Feng J, Yang D, Fu L, Yan X (2012) CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci U S A 109(4):1127–1132PubMedCentralPubMedCrossRef

19.

Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I (2006) MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression. Mol Cancer 5:57PubMedCentralPubMedCrossRef

20.

Woo JC, Yu T, Hurd TC (2003) Breast cancer in pregnancy: a literature review. Arch Surg 138(1):91–98 (discussion 99)PubMedCrossRef

21.

Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Husing A, Kaaks R, Koskela P, Grankvist K, Pukkala E, Zeleniuch-Jacquotte A, Lehtinen M, Toniolo P (2012) Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer. Int J Cancer 130(4):910–920PubMedCentralPubMedCrossRef

22.

Haughian JM, Pinto MP, Harrell JC, Bliesner BS, Joensuu KM, Dye WW, Sartorius CA, Tan AC, Heikkila P, Perou CM, Horwitz KB (2012) Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch. Proc Natl Acad Sci USA 109(8):2742–2747PubMedCentralPubMedCrossRef

23.

Tartakover-Matalon S, Mizrahi A, Epstein G, Shneifi A, Drucker L, Pomeranz M, Fishman A, Radnay J, Lishner M (2010) Breast cancer characteristics are modified by first trimester human placenta: in vitro co-culture study. Hum Reprod 25(10):2441–2454PubMedCrossRef

24.

Holtan SG, Creedon DJ, Haluska P, Markovic SN (2009) Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc 84(11):985–1000PubMedCentralPubMedCrossRef

25.

Genbacev Olga, Schubach Stephanie A, Miller Richard K (1992) Villous culture of first trimester human placenta-model to study extravillous trophoblast (EVT) differentiation. Placenta 13(5):439–461PubMedCrossRef

26.

Genbacev O, Jensen KD, Powlin SS, Miller RK (1993) In vitro differentiation and ultrastructure of human extravillous trophoblast (EVT) cells. Placenta 14(4):463–475PubMedCrossRef

27.

Shochet Epstein (2012) G., S. Tartakover Matalon, L. Drucker, M. Pomeranz, A. Fishman, G. Rashid, V. Oron-Karni, M. Pasmanik-Chor, and M. Lishner, Hormone-dependent placental manipulation of breast cancer cell migration. Hum Reprod 27(1):73–88CrossRef

28.

Chu Y-W, Wang R, Schmid I, Sakamoto M (1999) Analysis with flow cytometry of green fluorescent protein expression in leukemic cells. Cytometry 36(4):333–339PubMedCrossRef

29.

Keller A, Backes C, Al-Awadhi M, Gerasch A, Kuntzer J, Kohlbacher O, Kaufmann M, Lenhof HP (2008) GeneTrailExpress: a web-based pipeline for the statistical evaluation of microarray experiments. BMC Bioinformatics 9:552PubMedCentralPubMedCrossRef

30.

Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10:48PubMedCentralPubMedCrossRef

31.

Na YR, Seok SH, Kim DJ, Han JH, Kim TH, Jung H, Lee BH, Park JH (2009) Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci 100(11):2218–2225PubMedCrossRef

32.

Drabsch Y, Ten Dijke P (2011) TGF-beta signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplas 16(2):97–108CrossRef

33.

Al Saleh S, Al Mulla F, Luqmani YA (2011) Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells. PLoS ONE 6(6):e20610PubMedCentralPubMedCrossRef

34.

Band AM, Laiho M (2011) Crosstalk of TGF-beta and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neopl 16(2):109–115CrossRef

35.

Pereg D, Koren G, Lishner M (2008) Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev 34(4):302–312PubMedCrossRef

36.

Jackisch C, Louwen F, Schwenkhagen A, Karbowski B, Schmid KW, Schneider HP, Holzgreve W (2003) Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet 268(2):69–77PubMed

37.

Mitchell MJ, King MR (2013) Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol 3:44PubMedCentralPubMedCrossRef

38.

Liu Q, Zhang Y, Mao H, Chen W, Luo N, Zhou Q, Yu X (2012) A crosstalk between the Smad and JNK signaling in the TGF-beta-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells. PLoS ONE 7(2):e32009PubMedCentralPubMedCrossRef

39.

Velden JL, Alcorn JF, Guala AS, Badura EC, Janssen-Heininger YM (2011) c-Jun N-terminal kinase 1 promotes transforming growth factor-beta1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3. Am J Respir Cell Mol Biol 44(4):571–581PubMedCentralPubMedCrossRef

40.

Mott JD, Werb Z (2004) Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16(5):558–564PubMedCentralPubMedCrossRef

41.

Kalkhoven E, Roelen BA, De Winter JP, Mummery CL, Van Den Eijnden-Van Raaij AJ, Van Der Saag PT, Van Der Burg B (1995) Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 6(9):1151–1161PubMed

42.

Chen L, Mayer JA, Krisko TI, Speers CW, Wang T, Hilsenbeck SG, Brown PH (2009) Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Res 69(23):8853–8861PubMedCentralPubMedCrossRef

43.

Coradini D, Fornili M, Ambrogi F, Boracchi P, Biganzoli E (2012) TP53 mutation, epithelial–mesenchymal transition, and stemlike features in breast cancer subtypes. J Biomed Biotechnol 2012:254085PubMedCentralPubMedCrossRef

44.

Lim LY, Vidnovic N, Ellisen LW, Leong CO (2009) Mutant p53 mediates survival of breast cancer cells. Br J Cancer 101(9):1606–1612PubMedCentralPubMedCrossRef

45.

Manaster I, Goldman-Wohl D, Greenfield C, Nachmani D, Tsukerman P, Hamani Y, Yagel S, Mandelboim O (2012) MiRNA-mediated control of HLA-G expression and function. PLoS ONE 7(3):e33395PubMedCentralPubMedCrossRef

Titel: Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway
verfasst von: Gali Epstein Shochet
Shelly Tartakover-Matalon
Liat Drucker
Metsada Pasmanik-Chor
Meir Pomeranz
Ami Fishman
Michael Lishner
Publikationsdatum: 01.12.2014
Verlag: Springer Netherlands
Erschienen in: Clinical & Experimental Metastasis / Ausgabe 8/2014
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-014-9683-0

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2014

Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer

Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone

Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK–NF-κB signaling pathway

TGFβ can stimulate the p38/β-catenin/PPARγ signaling pathway to promote the EMT, invasion and migration of non-small cell lung cancer (H460 cells)

Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling

Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie